450 related articles for article (PubMed ID: 26781205)
1. Enabling personalized cancer medicine decisions: The challenging pharmacological approach of PBPK models for nanomedicine and pharmacogenomics (Review).
Vizirianakis IS; Mystridis GA; Avgoustakis K; Fatouros DG; Spanakis M
Oncol Rep; 2016 Apr; 35(4):1891-904. PubMed ID: 26781205
[TBL] [Abstract][Full Text] [Related]
2. Nanomedicine and personalized medicine toward the application of pharmacotyping in clinical practice to improve drug-delivery outcomes.
Vizirianakis IS
Nanomedicine; 2011 Feb; 7(1):11-7. PubMed ID: 21094279
[TBL] [Abstract][Full Text] [Related]
3. Clinical translation of genotyping and haplotyping data: implementation of in vivo pharmacology experience leading drug prescription to pharmacotyping.
Vizirianakis IS
Clin Pharmacokinet; 2007; 46(10):807-24. PubMed ID: 17854232
[TBL] [Abstract][Full Text] [Related]
4. Physiologically-based pharmacokinetic models: approaches for enabling personalized medicine.
Hartmanshenn C; Scherholz M; Androulakis IP
J Pharmacokinet Pharmacodyn; 2016 Oct; 43(5):481-504. PubMed ID: 27647273
[TBL] [Abstract][Full Text] [Related]
5. PBPK models for the prediction of in vivo performance of oral dosage forms.
Kostewicz ES; Aarons L; Bergstrand M; Bolger MB; Galetin A; Hatley O; Jamei M; Lloyd R; Pepin X; Rostami-Hodjegan A; Sjögren E; Tannergren C; Turner DB; Wagner C; Weitschies W; Dressman J
Eur J Pharm Sci; 2014 Jun; 57():300-21. PubMed ID: 24060672
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomic Challenges in Cardiovascular Diseases: Examples of Drugs and Considerations for Future Integration in Clinical Practice.
Chatelin J; Stathopoulou MG; Arguinano AA; Xie T; Visvikis-Siest S
Curr Pharm Biotechnol; 2017; 18(3):231-241. PubMed ID: 28117005
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics: A strategy for personalized medicine for autoimmune diseases.
Tavakolpour S; Darvishi M; Ghasemiadl M
Clin Genet; 2018 Mar; 93(3):481-497. PubMed ID: 29194620
[TBL] [Abstract][Full Text] [Related]
8. The role of hospital pharmacists in the adoption and use of pharmacogenomics and precision medicine.
Schwartz EJ; Issa AM
Per Med; 2017 Jan; 14(1):27-35. PubMed ID: 29749827
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics, precision medicine, and implications for anesthesia care.
Kaye AD; Mahakian T; Kaye AJ; Pham AA; Hart BM; Gennuso S; Cornett EM; Gabriel RA; Urman RD
Best Pract Res Clin Anaesthesiol; 2018 Jun; 32(2):61-81. PubMed ID: 30322465
[TBL] [Abstract][Full Text] [Related]
10. Clinical Applications of Personalized Medicine: A New Paradigm and Challenge.
Di Sanzo M; Cipolloni L; Borro M; La Russa R; Santurro A; Scopetti M; Simmaco M; Frati P
Curr Pharm Biotechnol; 2017; 18(3):194-203. PubMed ID: 28240172
[TBL] [Abstract][Full Text] [Related]
11. Non-maturational covariates for dynamic systems pharmacology models in neonates, infants, and children: Filling the gaps beyond developmental pharmacology.
Allegaert K; Simons SHP; Tibboel D; Krekels EH; Knibbe CA; van den Anker JN
Eur J Pharm Sci; 2017 Nov; 109S():S27-S31. PubMed ID: 28506866
[TBL] [Abstract][Full Text] [Related]
12. [Translational approach for pharmacogenomics and personalized medicine].
Zhang W; Zhou HH
Yao Xue Xue Bao; 2011 Jan; 46(1):1-5. PubMed ID: 21465801
[TBL] [Abstract][Full Text] [Related]
13. [PHARMACOGENOMICS AND PERSONALIZED MEDICINE: TOWARDS A SYSTEMATIC GENOMIC SCREENING?].
Dideberg V; Segers K; Koopmansch B; Lambert F; Bours V
Rev Med Liege; 2015; 70(5-6):251-6. PubMed ID: 26285448
[TBL] [Abstract][Full Text] [Related]
14. The Daniel K. Inouye College of Pharmacy Scripts: Precision Medicine Through the Use of Pharmacogenomics: Current Status and Barriers to Implementation.
Ciarleglio AE; Ma C
Hawaii J Med Public Health; 2017 Sep; 76(9):265-269. PubMed ID: 28900583
[TBL] [Abstract][Full Text] [Related]
15. Pharmacogenomics: Driving Personalized Medicine.
Sadee W; Wang D; Hartmann K; Toland AE
Pharmacol Rev; 2023 Jul; 75(4):789-814. PubMed ID: 36927888
[TBL] [Abstract][Full Text] [Related]
16. 4th ESPT Conference: pharmacogenomics and personalized medicine - research progress and clinical implementation.
Sipeky C; Llerena A; Manolopoulos VG; Pearson E; Mlakar V; Gozzo L; Simmaco M; Marchetti P; Re MD; Stankovic S; Meyer U; Cascorbi I; Ingelman-Sundberg M; Suarez-Kurtz G; Marc J; Katsila T; Paulmichl M; Nofziger C; Ansari M; Drago F; van Schaik RH
Pharmacogenomics; 2019 Oct; 20(15):1063-1069. PubMed ID: 31588876
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenomics in Critical Care.
Cheek D; Howington L
AACN Adv Crit Care; 2018; 29(1):36-42. PubMed ID: 29496712
[TBL] [Abstract][Full Text] [Related]
18. Optimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling.
Moss DM; Siccardi M
Br J Pharmacol; 2014 Sep; 171(17):3963-79. PubMed ID: 24467481
[TBL] [Abstract][Full Text] [Related]
19. Integrating pharmacogenomics into pharmacy practice via medication therapy management.
Reiss SM;
J Am Pharm Assoc (2003); 2011; 51(6):e64-74. PubMed ID: 22001957
[TBL] [Abstract][Full Text] [Related]
20. Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience.
Knepper TC; Bell GC; Hicks JK; Padron E; Teer JK; Vo TT; Gillis NK; Mason NT; McLeod HL; Walko CM
Oncologist; 2017 Feb; 22(2):144-151. PubMed ID: 28179575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
